Aktionärsstruktur

Inhaber in %
Freefloat 99,63
Vanguard Group, Inc. (Subfiler) 7,95
The Vanguard Group, Inc. 7,59
Capital Research & Management Co. (Global Investors) 6,06
State Street Corp. 4,53
Vanguard Total Stock Market Index Fund 2,85
BlackRock Institutional Trust Co. NA 2,63
BlackRock Fund Advisors 2,57
Capital Income Builder 2,41
American Mutual Fund 2,31
American Funds Investment Company of America 2,18
Vanguard 500 Index Fund 2,07
Washington Mutual Investors Fund 1,83
Capital Research & Management Co. (World Investors) 1,68
Geode Capital Management LLC 1,48

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2015 2016 2017 2018 2019
Personal am Ende des Jahres 8.000 9.000 10.000 11.000 11.800
Umsatz pro Mitarbeiter in Mio. EUR 4,00 3,37 2,61 2,02 1,89

Bilanz (in Mio. EUR) - Aktiva

2015 2016 2017 2018 2019
Summe Umlaufvermögen 24.763 20.445 31.823 35.836 30.296
Summe Anlagevermögen 40.714 45.233 53.984 48.709 47.843
Summe Aktiva 51.839 56.977 70.283 63.675 61.627

Bilanz (in Mio. EUR) - Passiva

2015 2016 2017 2018 2019
Gesamtverschuldung/ -verbindlichkeiten 22.180 26.346 33.542 27.322 25.318
Summe Fremdkapital 32.726 37.614 49.782 42.141 38.977
Summe Eigenkapital 19.113 19.363 20.501 21.534 22.650
Summe Passiva 51.839 56.977 70.283 63.675 61.627

Adresse

333 Lakeside Drive, 94404 Foster City
Telefon +1 (650) 574-3000
Fax +1 (650) 578-9264
Internet http://www.gilead.com

Management

Andrew D. Dickinson
Chief Financial Officer
Brett A. Pletcher
Secretary, Chief Compliance Officer & Executive VP
Daniel P. O'Day
Chairman & Chief Executive Officer
Diane E. Wilfong
Chief Accounting Officer, Senior VP & Controller
Gayle Edlund Wilson
Independent Director
George Pratt Shultz
Director-Emeritus
Harish M. Manwani
Independent Director
Jacqueline K. Barton
Independent Director
Javier J. Rodriguez
Director
Johanna Mercier
Chief Commercial Officer
John Francis Cogan
Lead Independent Director
Jyoti Mehra
Executive Vice President-Human Resources
Kelly A. Kramer
Independent Director
Kevin E. Lofton
Independent Director
Linda Slanec Higgins
Senior VP-Research & External Innovation
Mark Genovese
Senior Vice President-Inflammation
Merdad V. Parsey
Chief Medical Officer
Michael Louie
Vice President-Information Systems
Per Wold-Olsen
Independent Director
Richard J. Whitley
Independent Director
Sandra J. Horning
Independent Director
Tomas Cihlar
Vice President-Virology
William A. Lee
Executive Vice President-Research